Loading...
Loading...
BIO| Name | Value |
|---|---|
| Revenues | 649.7M |
| Cost of Revenue | 294.9M |
| Gross Profit | 354.8M |
| Operating Expense | 296.4M |
| Operating I/L | 58.4M |
| Other Income/Expense | 803.3M |
| Interest Income | -50.6M |
| Pretax | 861.6M |
| Income Tax Expense | 818.8M |
| Net Income/Loss | 653.2M |
Bio-Rad Laboratories, Inc. operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops and markets reagents, laboratory instruments, and apparatus for research techniques, biopharmaceutical production, and food testing. It focuses on proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. The Clinical Diagnostics segment offers test systems, informatics systems, test kits, and quality controls for clinical laboratories. It provides reagents, instruments, and software for in vitro diagnostics tests. The company serves universities, medical schools, research organizations, government agencies, pharmaceutical and biotechnology companies, food producers, and testing laboratories.
